SCHEMBL6501526

SCHEMBL6501526

CCOC(=O)CCCOc1cc(C)c(NC(=S)NC)c(NCc2ccc(Cl)cc2Cl)c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC1 Q13547 1/20 0.39
HDAC8 Q9BY41 1/20 0.39
HDAC6 Q9UBN7 1/20 0.39
MEN1 O00255 7/20 0.38
KMT2A Q03164 7/20 0.38
MAPT P10636 7/20 0.38
ALDH1A1 P00352 4/20 0.38
LMNA P02545 2/20 0.38
ALOX12 P18054 2/20 0.38
HPGD P15428 2/20 0.37
PABPC1 P11940 1/20 0.37
TDP1 Q9NUW8 1/20 0.37
TP53 P04637 1/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
GAA P10253 1/20 0.36
BRD4 O60885 1/20 0.36
HTT P42858 1/20 0.36
MAPK1 P28482 1/20 0.35
KDM4E B2RXH2 1/20 0.35
MCL1 Q07820 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6831386 0.91 HDAC1 (0.41) HDAC1HDAC8HDAC6MEN1KMT2A
SCHEMBL6501801 0.83 HDAC1 (0.44) HDAC1HDAC8HDAC6MEN1KMT2A
SCHEMBL6489796 0.79 MAPT (0.42) HDAC1HDAC8HDAC6MEN1KMT2A
SCHEMBL6487898 0.78 MAPT (0.42) HDAC1HDAC8HDAC6MEN1KMT2A
SCHEMBL6490287 0.77 HDAC1 (0.39) HDAC1HDAC8HDAC6MEN1KMT2A
SCHEMBL6501452 0.75 IDO1 (0.41) HDAC1HDAC8HDAC6MEN1KMT2A
SCHEMBL6497406 0.72 BRD4 (0.41) MEN1KMT2AMAPTLMNAPABPC1
SCHEMBL6502885 0.69 SMN1; SMN2 (0.42) MEN1KMT2AMAPTALDH1A1LMNA
SCHEMBL6502915 0.69 SMN1; SMN2 (0.44) MEN1KMT2AMAPTALDH1A1LMNA
SCHEMBL6499126 0.68 DRD2 (0.39) MEN1KMT2AALDH1A1HPGDSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050014812-A1 Benzimidazole compounds FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2005-01-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050014812-A1 Benzimidazole compounds SLC5A1, SLC5A2, G6PD HDAC1 50/4885HDAC8 114/4885HDAC6 190/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.